NeuroPointDX Announces Confirmation of First-Generation Autism Diagnostic Panel
NeuroPointDX has validated 12 metabolic subtypes of autism spectrum disorder. The diagnostic blood test for ASD will be available later this year.
CEO Elizabeth Donley says, “This is a historic moment, not just for Stemina and NeuroPointDX, but for our knowledge and understanding of autism.”
- The NPDX #ASD test is a new tool to help children & families affected by #autism. The test measures differences in… https://t.co/UF4tdBRiR53 hours ago
- As a parent, you know your child—you know what feels like a typical behavior and what seems different and concernin… https://t.co/oVSmXZYjhR3 days ago
- Are autistic characters in fiction intended to serve as metaphors? If so, does inclusion trump intention, or should… https://t.co/3rHKlRm8N54 days ago